Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-8 of 8 for your search:
Drug:
sulofenur
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Study of LY186641 (a Sulfonylurea) in Patients with Advanced and/or Metastatic Carcinoma of the Pancreas (Summary Last Modified 03/90)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
19 to 75
Sponsor:
Protocol IDs:
UNMC-38089
, NCI-V89-0270
2.
Phase II Study of LY186641 in Patients with Metastatic or Locally Recurrent Renal Cell Carcinoma (Summary Last Modified 08/90)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
over 18
Sponsor:
Protocol IDs:
CAN-NCIC-IND46
, NCI-V90-0028, IND46
3.
Phase II Study of LY186641 (a Sulfonylurea) Administered Daily for 14 Days in Patients with Advanced, Recurrent, or Metastatic Breast Cancer (Summary Last Modified 02/90)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
GUMC-18289
, NCI-V89-0277
4.
Phase II Study of LY186641 in Patients with Extensive Small Cell Lung Cancer (Summary Last Modified 07/90)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
CAN-NCIC-IND47
, NCI-V90-0029, IND47
5.
Phase II Study of LY186641 for Patients with Advanced (Stage IIIB or IV) or Recurrent non-Small Cell Lung Cancer (Summary Last Modified 08/90)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
MDA-DM-89030
, NCI-V90-0014
6.
Phase II Study of LY186641 in Patients with Refractory Epithelial Carcinoma of the Ovary (Summary Last Modified 06/90)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to physiologic 70
Sponsor:
Protocol IDs:
MDA-ID-89012
, NCI-V89-0251
7.
Phase II Study of LY186641 (a Sulfonylurea) in Patients with Locally Advanced and/or Metastatic Carcinoma of the Pancreas (Summary Last Modified 09/90)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
GUMC-690
, NCI-V90-0121
8.
Phase I Study of Sulofenur (LY186641) in Pediatric Patients with Refractory Solid Tumors (Summary Last Modified 11/93)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
under 21 at diagnosis
Sponsor:
NCI
Protocol IDs:
SJCRH-LY-SUL
, NCI-T91-0172D, T91-0172
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute